Serum IL-10, IL-17 and IL-23 levels as “bioumoral bridges” between dyslipidemia and atopy

These findings support the notion that dyslipidemia and atopic predisposition share the same immune pathways as well as they offer new insights in the complex crosstalk between hyperlipidemia and atopy.